![](/img/cover-not-exists.png)
E24Overall survival (OS) of selected patients (Pts) with non-small cell lung cancer (NSCLC) receiving nivolumab beyond progression
Genova, C, Rijavec, E, Rossi, G, Biello, F, Barletta, G, Tagliamento, M, Grossi, FVolume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx426.023
Date:
October, 2017
File:
PDF, 47 KB
english, 2017